Oncologisch Centrum

  • A A
  • fr
  • en
  • Home
  • Vacatures
  • Contact
  • sitemap
  • FAQ
  • Links
  • Pers
  • Raadpleging
  • Zorgaanbod
  • Zorgprogramma's
  • Klinische studies
  • Onc. Research Centre
  • Activiteiten

U bent hier: UZ Brussel Diensten Ziekenhuis volwassenen Oncologisch Centrum Zorgaanbod Familiale kanker Publicaties

  • Medische oncologie
  • Radiotherapie
  • Oncologische heelkunde
  • Borstkliniek
  • Kankerpreventie en opsporing
  • Familiale kanker
    • Wat doen we?
    • Wie zijn we?
    • Raadpleging
    • Praatgroep
    • Publicaties
  • Hemato-oncologie
  • Multipel Myeloom Centrum Brussel (MCB)
  • Urologische oncologie
  • Supportieve en palliatieve zorg
  • Sociaal verpleegkundigen
  • DiĆ«tisten
  • Psychologen
  • Oncologische revalidatie
  • Datamanagement

Print

Publicaties

  •    2006
  •    2005
  •    2004
  •    2003
  •    2002
  •    1999
  •    1997

2006

Sylvia De Brakeleer, Marika Bogdani, Jacques De Grève, Julie Decock, Erica Sermijn, Maryse Bonduelle, Guido Goelen, and Erik Teugels. Loss of nuclear BRCA protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers. Submitted to Clinical Cancer Research 2006

2005

Erik Teugels, Guido Goelen, Sylvia De Brakeleer, Willy Lissens, Erica Sermijn, and Jacques De Grève. De Novo Alu element insertions targeted to a common sequence within the BRCA1 and BRCA2 genes. Hum Mutat..2005 Sep;26(3):284.

2004

Sermijn E, Goelen G, Teugels E, Kaufman L, Bonduelle M, Neyns B, Poppe B, De Paepe A, De Greve J. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet, 2004

2003

G. Goelen, E. Teugels, E. Sermijn, M. Bonduelle, B. Neyns, J. De Greve. Comparing the performance of clinical family characteristics and probability models for predicting the identification of germline BRCA1/2 mutations in breast cancer families.Arch Public Health 2003;61:297-312.

2002

Krajc M, De Greve J, Goelen G, Teugels E. BRCA2 founder mutation in Slovenian breast cancer families. Eur J Hum Genet. 2002 Dec; 10(12): 879-82.

Bogdani M, Teugels E, De Greve J, Bourgain C, Neyns B, Pipeleers-Marichal M. Loss of nuclear BRCA1 localization in breast carcinoma is age dependent. Virchows Arch. 2002 Mar; 440(3): 274-9.

1999

Goelen G, Rigo A, Bonduelle M, De Greve J. BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients. Ann N Y Acad Sci. 1999; 889: 240-3.

Goelen G, Rigo A, Bonduelle M, De Greve J. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing. J Clin Oncol. 1999 May; 17(5): 1595-600.

Goelen G, Teugels E, Bonduelle M, Neyns B, De Greve J. High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects. J Med Genet. 1999 Apr; 36(4): 304-8.

1997

Goelen G, Rigo A, Neyns B, Betz W, De Greve J. Ethical aspects of genetic counseling in familial breast and ovarian cancer. Combining applied theory and reflective practice. Ann N Y Acad Sci. 1997 Dec 29; 833: 170-2.

Goelen G, Rigo A, Teugels E, Neyns B, Bonduelle M, De Greve J. Ethical issues in breast and ovarian cancer genetic counseling. J Genet Couns. 1997 Dec; 6(4): 497-8

Top
 
Universitair Ziekenhuis Brussel Campus Jette - Laarbeeklaan 101 - 1090 Brussel - T: 02 477 41 11 © 2012 | Disclaimer